Paolo Graziano

38PUBLICATIONS
118CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Aug 27, 2026
Standardizing pCR/MPR Assessment in NSCLC After Neoadjuvant Therapy: Challenges and Perspectives.

|May 13, 2026
Role of Maximum Standardized Uptake Volume in Predicting Tumor Spread Through Air Spaces in Stage IA Lung Cancers Smaller than 2 cm.

|Jun 26, 2025
Loss of MTAP expression is not an accurate surrogate for CDKN2A homozygous deletions in peritoneal mesothelioma.

Andrea Quaranta, Andrea Marzullo, Francesco Fortarezza

|Mar 13, 2025
Distribution of EGFR and KRAS Mutations in Patients with Surgically Resected Non-Small Cell Lung Cancer from Southern Italy: Real-Life Data from a Single Institution and Literature Review.

Michele Piazzolla, Paola Parente, Flavia Centra

|Nov 27, 2024
Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer.

Paola Parrella, Raffaela Barbano, Katharina Jonas

|Jul 27, 2024
Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer.

Antonella Centonza, Tommaso Mazza, Domenico Trombetta

Pageof 7

Frequent Collaborators

11 joint publications

Paola Parente

8 joint publications

Lucia Anna Muscarella

6 joint publications

Giancarlo Troncone

5 joint publications

Umberto Malapelle